Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcadia Biosciences (RKDA) Shares Outstanding (Diluted Average) (2021 - 2025)

Arcadia Biosciences filings provide 5 years of Shares Outstanding (Diluted Average) readings, the most recent being $1.4 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) changed 0.35% to $1.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 million, a 0.35% change, with the full-year FY2025 number at $1.4 million, changed 0.35% from a year prior.
  • Shares Outstanding (Diluted Average) hit $1.4 million in Q4 2025 for Arcadia Biosciences, roughly flat from $1.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $21.7 million in Q2 2021 to a low of $532016.0 in Q4 2021.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $1.4 million (2024), compared with a mean of $3.2 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): tumbled 97.45% in 2022 and later skyrocketed 144.88% in 2023.
  • Arcadia Biosciences' Shares Outstanding (Diluted Average) stood at $532016.0 in 2021, then rose by 12.66% to $599389.0 in 2022, then surged by 106.37% to $1.2 million in 2023, then grew by 10.22% to $1.4 million in 2024, then rose by 0.35% to $1.4 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $1.4 million (Q4 2025), $1.4 million (Q3 2025), and $1.4 million (Q2 2025) per Business Quant data.